The Bahal Research Lab

Dr. Bahal’s research lab integrates chemical biology of nucleic acid analogues and new polymeric delivery strategies to target genetic diseases and various kinds of cancer. His group’s major research interests include (1) selective targeting of microRNA and mRNA using antisense based scaffolds delivered via nanotechnology, (2) exploring the design and engineering of genome targeted nucleic acid analogues towards next-generation human therapeutics, and (3) selective targeting of tumor cells in tumor microenvironment using novel peptide and peptidomimetics based modules.